Suppr超能文献

经皮射频消融治疗肾细胞癌的疗效改善:73例患者术中超声造影的回顾性研究

Improved outcome of percutaneous radiofrequency ablation in renal cell carcinoma: a retrospective study of intraoperative contrast-enhanced ultrasonography in 73 patients.

作者信息

Zhao Xiaozhi, Wang Wei, Zhang Shiwei, Liu Jun, Zhang Fan, Ji Changwei, Li Xiaogong, Gan Weidong, Zhang Gutian, Guo Hongqian

机构信息

Urology Department, The Affiliated Nanjing Drum Tower Hospital, Nanjing University Medical School, 321 Zhongshan Road, Nanjing, 210008, Jiangsu, China.

出版信息

Abdom Imaging. 2012 Oct;37(5):885-91. doi: 10.1007/s00261-011-9828-4.

Abstract

OBJECTIVES

To evaluate the impact of contrast-enhanced ultrasonography (CEUS) during percutaneous radiofrequency ablation (PRFA) procedure in renal cell carcinoma (RCC).

METHODS

From January 2008 to July 2010, 73 patients with sporadic unilateral RCC were enrolled to our study (57 men and 16 women, age range: 37-78 years, mean age 57.9 years). The diameter of the tumor was 1.7-5.8, 3.4 cm on average. The patients were divided into two groups depending on the intraoperative ultrasonography type: CEUS group and conventional ultrasound group. Patients in CEUS group received CEUS before insertion of the electrode, and the second CEUS was performed right after the initial ablation to dynamically evaluate the images. If there was highly suspicious residue, additional ablation and repeated CEUS were applied. Patients in the conventional ultrasound group received PRFA guided by gray-scale ultrasound. All of these patients received contrast-enhanced computed tomography (CT) examination 7 days after the procedure (patients in CEUS group received CEUS conducted with each CT scan), with subsequent CT and CEUS assessment at 3, 6, and every 6 months thereafter.

RESULTS

The mean follow-up period was 22 months (range: 12-42 months). All tumors were biopsied before RFA. The local tumor control rate was 94.6% (35/37) in the CEUS group and 86.1% (31/36) in the conventional ultrasound group (P < 0.05); the cancer-specific survival rate and the overall survival rate were 100%. The post-RFA (12 months) mean GFR levels were 84.7 ± 27.5 mL/min/1.73 m(2) (P > 0.05, compared with pre-GFR: 86.4 ± 26.2 mL/min/1.73 m(2)) in the CEUS group and 81.9 ± 22.8 mL/min/1.73 m(2) (P > 0.05, compared with pre-GFR: 83.5 ± 23.7 mL/min/1.73 m(2)) in the conventional ultrasound group.

CONCLUSION

Intraoperative CEUS can "real-time" monitor the ablated area during PRFA procedure. This technique can help to achieve a higher success rate compared with conventional ultrasound. No impact of intraoperative CEUS has been found on GFR level.

摘要

目的

评估超声造影(CEUS)在肾细胞癌(RCC)经皮射频消融(PRFA)手术中的作用。

方法

2008年1月至2010年7月,73例散发性单侧RCC患者纳入本研究(57例男性和16例女性,年龄范围:37 - 78岁,平均年龄57.9岁)。肿瘤直径为1.7 - 5.8 cm,平均3.4 cm。根据术中超声检查类型将患者分为两组:CEUS组和传统超声组。CEUS组患者在插入电极前接受CEUS检查,初次消融后立即进行第二次CEUS检查以动态评估图像。如果有高度可疑残留,则进行额外消融并重复CEUS检查。传统超声组患者在灰阶超声引导下接受PRFA治疗。所有这些患者在术后7天接受增强计算机断层扫描(CT)检查(CEUS组患者在每次CT扫描时接受CEUS检查),随后在3、6个月及之后每6个月进行CT和CEUS评估。

结果

平均随访期为22个月(范围:12 - 42个月)。所有肿瘤在RFA前均进行活检。CEUS组局部肿瘤控制率为94.6%(35/37),传统超声组为86.1%(31/36)(P < 0.05);癌症特异性生存率和总生存率均为100%。CEUS组RFA后(12个月)平均肾小球滤过率(GFR)水平为84.7 ± 27.5 mL/min/1.73 m²(与RFA前GFR:86.4 ± 26.2 mL/min/1.73 m²相比,P > 0.05),传统超声组为81.9 ± 22.8 mL/min/1.73 m²(与RFA前GFR:83.5 ± 23.7 mL/min/1.73 m²相比,P > 0.05)。

结论

术中CEUS可在PRFA手术过程中“实时”监测消融区域。与传统超声相比,该技术有助于提高成功率。未发现术中CEUS对GFR水平有影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验